BioLineRx Ltd. (BLRX)
2.216
+0.01
(+0.27%)
USD |
NASDAQ |
Oct 09, 16:00
2.22
0.00 (0.00%)
After-Hours: 20:00
BioLineRx EPS Diluted (Quarterly) : -0.6957 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.6957 |
| March 31, 2026 | -0.5804 |
| December 31, 2025 | -0.32 |
| September 30, 2025 | -0.223 |
| June 30, 2025 | -1.017 |
| March 31, 2025 | 1.379 |
| December 31, 2024 | -1.512 |
| September 30, 2024 | -0.0727 |
| June 30, 2024 | 0.006 |
| March 31, 2024 | -0.0096 |
| December 31, 2023 | -0.1917 |
| September 30, 2023 | -0.2587 |
| June 30, 2023 | -0.3014 |
| March 31, 2023 | -0.1977 |
| December 31, 2022 | -0.0931 |
| September 30, 2022 | -0.1386 |
| June 30, 2022 | -0.156 |
| March 31, 2022 | -0.1033 |
| December 31, 2021 | -0.0903 |
| September 30, 2021 | -0.121 |
| June 30, 2021 | -0.1534 |
| March 31, 2021 | -0.2733 |
| December 31, 2020 | -0.612 |
| September 30, 2020 | -0.2335 |
| June 30, 2020 | -0.4609 |
| Date | Value |
|---|---|
| March 31, 2020 | -0.5649 |
| December 31, 2019 | -0.9676 |
| September 30, 2019 | -0.3966 |
| June 30, 2019 | -0.5656 |
| March 31, 2019 | -0.6943 |
| December 31, 2018 | -0.7459 |
| September 30, 2018 | -0.8856 |
| June 30, 2018 | -0.6735 |
| March 31, 2018 | -0.8757 |
| December 31, 2017 | -1.075 |
| September 30, 2017 | -1.083 |
| June 30, 2017 | -0.781 |
| March 31, 2017 | -1.221 |
| December 31, 2016 | -1.202 |
| September 30, 2016 | -1.214 |
| June 30, 2016 | -1.063 |
| March 31, 2016 | -0.952 |
| December 31, 2015 | -1.052 |
| September 30, 2015 | -0.4527 |
| June 30, 2015 | -1.318 |
| March 31, 2015 | -1.396 |
| December 31, 2014 | -1.724 |
| September 30, 2014 | -0.2985 |
| June 30, 2014 | -1.819 |
| March 31, 2014 | -1.287 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| XTL Biopharmaceuticals Ltd. | -- |
| Kamada Ltd. | 0.1605 |
| Can-Fite BioPharma Ltd. | -- |
| Eocene Ltd. | -2.860 |
| Revium Recovery, Inc. | -0.0096 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -4.414M |
| Revenue (Quarterly) | 0.299M |
| Total Expenses (Quarterly) | 3.377M |
| Enterprise Value | 7.392M |
| Gross Profit Margin (Quarterly) | 53.41% |
| Profit Margin (Quarterly) | -1.48K% |
| Earnings Yield | -82.09% |
| Normalized Earnings Yield | -82.19 |